IL290019B2 - Peptides for regulating melanocytes - Google Patents

Peptides for regulating melanocytes

Info

Publication number
IL290019B2
IL290019B2 IL290019A IL29001922A IL290019B2 IL 290019 B2 IL290019 B2 IL 290019B2 IL 290019 A IL290019 A IL 290019A IL 29001922 A IL29001922 A IL 29001922A IL 290019 B2 IL290019 B2 IL 290019B2
Authority
IL
Israel
Prior art keywords
peptide
alkyl
group
pharmaceutical
arg
Prior art date
Application number
IL290019A
Other languages
English (en)
Hebrew (he)
Other versions
IL290019A (en
IL290019B1 (en
Inventor
Laura Nevola
Martin Santiago Esteban
Original Assignee
Idp Discovery Pharma S L
Laura Nevola
Martin Santiago Esteban
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idp Discovery Pharma S L, Laura Nevola, Martin Santiago Esteban filed Critical Idp Discovery Pharma S L
Publication of IL290019A publication Critical patent/IL290019A/en
Publication of IL290019B1 publication Critical patent/IL290019B1/en
Publication of IL290019B2 publication Critical patent/IL290019B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
IL290019A 2019-08-02 2020-07-31 Peptides for regulating melanocytes IL290019B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382674 2019-08-02
PCT/EP2020/071629 WO2021023646A1 (en) 2019-08-02 2020-07-31 Melanocyte-regulating peptides

Publications (3)

Publication Number Publication Date
IL290019A IL290019A (en) 2022-03-01
IL290019B1 IL290019B1 (en) 2025-09-01
IL290019B2 true IL290019B2 (en) 2026-01-01

Family

ID=67658460

Family Applications (1)

Application Number Title Priority Date Filing Date
IL290019A IL290019B2 (en) 2019-08-02 2020-07-31 Peptides for regulating melanocytes

Country Status (14)

Country Link
US (1) US12492225B2 (https=)
EP (1) EP4007563A1 (https=)
JP (2) JP2022542512A (https=)
KR (1) KR20220041094A (https=)
CN (1) CN114245800A (https=)
AR (1) AR119529A1 (https=)
AU (1) AU2020325636A1 (https=)
BR (1) BR112022001729A2 (https=)
CA (1) CA3148785A1 (https=)
CL (1) CL2022000208A1 (https=)
IL (1) IL290019B2 (https=)
MX (1) MX2022001114A (https=)
TW (1) TWI889695B (https=)
WO (1) WO2021023646A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116120401B (zh) * 2023-03-22 2025-09-30 中国科学院昆明动物研究所 一种抗黑色素瘤活性多肽kw13、药物及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106491A2 (en) * 2002-06-18 2003-12-24 Cepep Ab Cell penetrating peptides
WO2019115480A1 (en) * 2017-12-12 2019-06-20 Protagen Ag Melanoma checkpoint inhibitor detection and treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060014712A1 (en) * 2004-05-30 2006-01-19 Cemines, Inc. Controlled delivery of therapeutic compounds
CN106011233A (zh) * 2010-08-13 2016-10-12 莫尔豪斯医学院 中风的生物标记
DK3430031T3 (da) * 2016-03-15 2022-01-17 Idp Discovery Pharma S L Peptider med anti-kræftaktivitet
AU2018311130A1 (en) * 2017-08-02 2020-02-20 Idp Discovery Pharma, S.L. Anticancer peptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106491A2 (en) * 2002-06-18 2003-12-24 Cepep Ab Cell penetrating peptides
WO2019115480A1 (en) * 2017-12-12 2019-06-20 Protagen Ag Melanoma checkpoint inhibitor detection and treatment

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HIDEKI MURAKAMI ET AL:, SUMOYLATION MODULATES TRANSCRIPTIONAL ACTIVITY OF MITF IN A PROMOTER SPECIFIC MANNER: SUMOYLATION MODULATES TRANSCRIPTIONAL ACTIVITY OF MITF, 15 June 2005 (2005-06-15) *
HSIAO JENNIFER J ET AL:, THE ROLES OF MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR AND PIGMENTATION IN MELANOMA, 9 August 2014 (2014-08-09) *
MURAKAMI M ET AL:, TRANSCRIPTIONAL ACTIVATION OF MOUSE MAST CELL PROTEASE-9 BY MICROPHTHALMIA- ASSOCIATED TRANSCRIPTION FACTOR, 7 November 2003 (2003-11-07) *

Also Published As

Publication number Publication date
CL2022000208A1 (es) 2022-09-09
IL290019A (en) 2022-03-01
TW202120117A (zh) 2021-06-01
CA3148785A1 (en) 2021-02-11
TWI889695B (zh) 2025-07-11
AR119529A1 (es) 2021-12-22
JP2025131623A (ja) 2025-09-09
US20230312649A1 (en) 2023-10-05
KR20220041094A (ko) 2022-03-31
AU2020325636A1 (en) 2022-02-10
IL290019B1 (en) 2025-09-01
JP2022542512A (ja) 2022-10-04
BR112022001729A2 (pt) 2022-04-12
MX2022001114A (es) 2022-05-03
WO2021023646A1 (en) 2021-02-11
US12492225B2 (en) 2025-12-09
CN114245800A (zh) 2022-03-25
EP4007563A1 (en) 2022-06-08

Similar Documents

Publication Publication Date Title
US20210008159A1 (en) Peptides with anti-cancer activity
JP2025131623A (ja) メラノサイト調節ペプチド
KR20200033936A (ko) 항암 펩타이드
AU2018311129B2 (en) Anticancer peptides
RU2835064C2 (ru) Меланоцит-регулирующие пептиды
JP7361689B2 (ja) 抗がんペプチド
CA3017424C (en) Peptides with anti-cancer activity